{"title":"Department of Error","authors":"","doi":"10.1016/s0140-6736(25)00352-6","DOIUrl":null,"url":null,"abstract":"<em>André T, Elez E, Lenz H-J,et al. Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.</em> Lancet <em>2025; <strong>405:</strong> 383–95</em>—The appendix of this Article has been corrected as of Feb 27, 2025.","PeriodicalId":22898,"journal":{"name":"The Lancet","volume":"85 3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s0140-6736(25)00352-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
André T, Elez E, Lenz H-J,et al. Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial. Lancet 2025; 405: 383–95—The appendix of this Article has been corrected as of Feb 27, 2025.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
